Company · CIK 1894525

# Apimeds Pharmaceuticals US, Inc.

| CIK | [1894525](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001894525) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | APUS (NYSE) |
| First annual or quarterly report | 2025-04-15 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-282324 | IPO Final prospectus | 2024-09-25 | 2025-05-09 | 11 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-05-09 | [424B4](https://www.sec.gov/Archives/edgar/data/1894525/000121390025041193/0001213900-25-041193-index.htm) Final prospectus | 333-282324 | 0001213900-25-041193 |
| 2025-05-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894525/999999999525001413/9999999995-25-001413-index.htm) Declared effective | 333-282324 | 9999999995-25-001413 |
| 2025-02-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894525/999999999525000387/9999999995-25-000387-index.htm) Declared effective | 333-282324 | 9999999995-25-000387 |
| 2025-02-10 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390025011555/0001213900-25-011555-index.htm) Amendment | 333-282324 | 0001213900-25-011555 |
| 2025-02-06 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390025010958/0001213900-25-010958-index.htm) Amendment | 333-282324 | 0001213900-25-010958 |
| 2025-01-29 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390025007894/0001213900-25-007894-index.htm) Amendment | 333-282324 | 0001213900-25-007894 |
| 2025-01-10 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390025002220/0001213900-25-002220-index.htm) Amendment | 333-282324 | 0001213900-25-002220 |
| 2024-12-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390024110650/0001213900-24-110650-index.htm) Amendment | 333-282324 | 0001213900-24-110650 |
| 2024-12-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390024106589/0001213900-24-106589-index.htm) Amendment | 333-282324 | 0001213900-24-106589 |
| 2024-11-08 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894525/000121390024095559/0001213900-24-095559-index.htm) Amendment | 333-282324 | 0001213900-24-095559 |
| 2024-09-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1894525/000121390024081766/0001213900-24-081766-index.htm) Registration filed | 333-282324 | 0001213900-24-081766 |
| 2024-01-29 | [DRS](https://www.sec.gov/Archives/edgar/data/1894525/000121390024007296/0001213900-24-007296-index.htm) Draft made public | 377-07074 | 0001213900-24-007296 |

[All filings of this company](https://equitycapital.markets/filings?cik=1894525) · [CSV](https://equitycapital.markets/filings.csv?cik=1894525)

---
Source page: https://equitycapital.markets/company/1894525 · Data: U.S. SEC EDGAR · CC BY 4.0